AU2003287081A1 - Clofarabine and taxane chemotherapy combination - Google Patents

Clofarabine and taxane chemotherapy combination

Info

Publication number
AU2003287081A1
AU2003287081A1 AU2003287081A AU2003287081A AU2003287081A1 AU 2003287081 A1 AU2003287081 A1 AU 2003287081A1 AU 2003287081 A AU2003287081 A AU 2003287081A AU 2003287081 A AU2003287081 A AU 2003287081A AU 2003287081 A1 AU2003287081 A1 AU 2003287081A1
Authority
AU
Australia
Prior art keywords
clofarabine
chemotherapy combination
taxane chemotherapy
taxane
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287081A
Other versions
AU2003287081A8 (en
Inventor
Katherine Stephenson
Steven D. Weitman
Sean T. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ilex Products Inc
Original Assignee
Ilex Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ilex Products Inc filed Critical Ilex Products Inc
Publication of AU2003287081A8 publication Critical patent/AU2003287081A8/en
Publication of AU2003287081A1 publication Critical patent/AU2003287081A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003287081A 2002-10-16 2003-10-14 Clofarabine and taxane chemotherapy combination Abandoned AU2003287081A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41893802P 2002-10-16 2002-10-16
US60/418,938 2002-10-16
US45951203P 2003-04-01 2003-04-01
US60/459,512 2003-04-01
PCT/US2003/032516 WO2004035034A2 (en) 2002-10-16 2003-10-14 Clofarabine and taxane chemotherapy combination

Publications (2)

Publication Number Publication Date
AU2003287081A8 AU2003287081A8 (en) 2004-05-04
AU2003287081A1 true AU2003287081A1 (en) 2004-05-04

Family

ID=32110200

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287081A Abandoned AU2003287081A1 (en) 2002-10-16 2003-10-14 Clofarabine and taxane chemotherapy combination

Country Status (2)

Country Link
AU (1) AU2003287081A1 (en)
WO (1) WO2004035034A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1875936B (en) * 2006-07-18 2010-05-19 济南康泉医药科技有限公司 Anticancer sustained release agent containing clorfarabine and cytotoxic drug

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034518A (en) * 1989-05-23 1991-07-23 Southern Research Institute 2-fluoro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl) adenine nucleosides
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
US20020182204A1 (en) * 2001-03-23 2002-12-05 Marie-Christine Bissery Combination of a taxane and a cyclin-dependent kinase

Also Published As

Publication number Publication date
AU2003287081A8 (en) 2004-05-04
WO2004035034A2 (en) 2004-04-29
WO2004035034A3 (en) 2004-07-22

Similar Documents

Publication Publication Date Title
AU2003241340A1 (en) Preparing and presenting content
AU2003286819A1 (en) Alternate delivery location methods and systems
EP1573463A3 (en) Alternate delivery location methods and systems
EP1545481A4 (en) Combination chemotherapy compositions and methods
AU2003258714A1 (en) Immune modulatory compounds and methods
AU2003280484A1 (en) Slide show with audio
AU2002364051A1 (en) Anti-cancer combination and use thereof
GB0207362D0 (en) Chemotherapy
GB0208516D0 (en) Chemotherapy
AU2003209316A1 (en) Combination table-mitter saw and assembly
AU2002354472A1 (en) Combine
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2003227074A1 (en) Perspiration insert
AU2003214038A1 (en) Peptides with anti-hypertensive properties
AU2002355026A1 (en) Combine
AU2003304548A1 (en) Enriched rice or enriched wheat
AU2003287081A1 (en) Clofarabine and taxane chemotherapy combination
AU2003302173A1 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003277416A1 (en) Clofarabine and platinum chemotherapy combination
AU2003236937A1 (en) School supply - universal
AU2003301245A1 (en) Clofarabine and camptothecin chemotherapy combination
EP1504541B8 (en) Rake-demodulator with multicode-finger
AU2003216442A1 (en) Enkurin and uses thereof
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
GB0427089D0 (en) Interaction between HSP90 and P50CDC37

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase